Blog Archives

Blog

How does a clinical development plan help drug programs?

How important is a clinical development plan? Your biotechnology start-up’s candidate asset has an intriguing…

CertaraJuly 26, 2024

Blog

What is a Scientific & Medical Publications Professional?

Would your drug development program benefit from partnering with experts in scientific and medical communications…

CertaraJuly 19, 2024

Blog

Tech debt in software ownership and SaaS

Technical debt is unavoidable. How do you mitigate associated risks?

CertaraJuly 19, 2024

Blog

New Feature Release: Reaction Enumeration in Design Hub

CertaraJuly 16, 2024

Blog

Pinnacle 21 Enterprise Analytics: Case Studies from the Field

In this blog, we look at some examples of how Pinnacle 21 Enterprise Analytics (P21E)…

CertaraJuly 15, 2024

Blog

Drug Discovery Platform Unlocks Scientific Data Access

The D360 desktop application supports drug discovery workflows, data access, and early development research data…

CertaraJuly 12, 2024

Blog

3 Things You Should Know About ADaM Standards

Learn the key aspects of ADaM standards, including the difference between SDTM and ADaM and…

CertaraJuly 4, 2024

Blog

Categorizing & Managing Risks in Aggregate Safety Reports

Categorizing Risks From a sponsor’s first authorization to conduct a clinical drug trial in any…

CertaraJune 28, 2024

Blog

Future Clinical Study Design: CDISC, FHIR, OMOP, or Hybrid Model?

June 27, 2024 Advances in technology and changes to the regulatory environment have resulted in…

CertaraJune 27, 2024

Blog

Generative AI Tools for Regulatory Writing

Regulatory writing is a crucial component of the drug development process. Regulatory writers must understand…

CertaraJune 20, 2024

Blog

How does a clinical development plan help drug programs?

What is a Scientific & Medical Publications Professional?

Tech debt in software ownership and SaaS

New Feature Release: Reaction Enumeration in Design Hub

Pinnacle 21 Enterprise Analytics: Case Studies from the Field

Drug Discovery Platform Unlocks Scientific Data Access

3 Things You Should Know About ADaM Standards

Categorizing & Managing Risks in Aggregate Safety Reports

Future Clinical Study Design: CDISC, FHIR, OMOP, or Hybrid Model?

Generative AI Tools for Regulatory Writing

Newsletter sign up

Quick links

Solutions

Contact